{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"EIF1AX, a translation initiation factor, is most frequently altered by mutation in uveal melanomas and papillary thyroid carcinomas.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"08/26/2019",
  "mutationEffect":{
    "citations":{
      "abstracts":[
        {
          "abstract":"Krishnamoorthy et al. Abstract# 892, AACR 2016",
          "link":"http://cancerres.aacrjournals.org/content/76/14_Supplement/892"
        }
      ],
      "pmids":[
        "26878173"
      ]
    },
    "description":"The EIF1AX A113_splice mutation is located in the C-terminus of the protein and results in either a cryptic splice variant or a truncated version of the protein. This mutation is found in thyroid tumors (PMID: 26878173). In vitro studies demonstrated that this mutation is activating, as shown by increased protein activity resulting in an increased rate of protein synthesis (Abstract: Krishnamoorthy et al. Abstract# 892, AACR 2016. http://cancerres.aacrjournals.org/content/76/14_Supplement/892).",
    "knownEffect":"Likely Gain-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"X113_splice",
    "alterationType":null,
    "consequence":"splice_acceptor_variant",
    "entrezGeneId":1964,
    "hgvs":null,
    "hugoSymbol":"EIF1AX",
    "id":null,
    "proteinEnd":113,
    "proteinStart":113,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The EIF1AX X113_splice alteration is likely oncogenic.",
  "vus":false
}